The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Trial Profile

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 27 Apr 2016 Planned End Date changed from 1 Sep 2015 to 1 Dec 2016.
    • 27 Apr 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top